# Glucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM)

> **NCT00862589** · NA · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 20 (actual)

## Conditions studied

- Hyperglycemia
- Hyperglucagonemia
- Glucose Intolerance

## Interventions

- **OTHER:** GLP-1 infusion

## Key facts

- **NCT ID:** NCT00862589
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2009-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00862589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00862589, "Glucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00862589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*